Organization Overview
Alternative names
aldesleukin (Proleukin) (1 trial)
bifidobacterium breve (1 trial)
bifidobacterium infantis (1 trial)
daclizumab (Zenapax) (1 trial)
everolimus (zortress) (1 trial)
labetuzumab govitecan (1 trial)
Adenocarcinoma (Phase 1)
Adenoma (Phase 3)
Adenomatous Polyposis Coli (Phase 3)
Breast Neoplasms (Phase 3)
Carcinoma (Phase 3)
Carcinoma, Adenoid Cystic (Phase 2)
Carcinoma, Ductal (Phase 2)
Carcinoma, Ductal, Breast (Phase 1)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Colorectal Neoplasms (Phase 3)
Duodenal Neoplasms (Phase 3)
Fever (Phase 1)
Gastrointestinal Neoplasms (Phase 2)
Laryngeal Diseases (Phase 3)
Leukemia (Phase 2)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Lung Neoplasms (Phase 2)
Melanoma (Phase 2)
Mucositis (Phase 2)
Multiple Myeloma (Phase 2)
Nasopharyngeal Neoplasms (Phase 3)
Neoplasms (Phase 3)
Neoplasms, Plasma Cell (Phase 2)
Neoplastic Cells, Circulating (Phase 2)
Neutropenia (Phase 2)
Ovarian Neoplasms (Phase 2)
Peritoneal Neoplasms (Phase 2)
Precancerous Conditions (Phase 1)
Primary Myelofibrosis (Phase 2)
Rectal Neoplasms (Phase 1)
Salivary Gland Neoplasms (Phase 2)
Uterine Cervical Neoplasms (Phase 2)